Montserrat Moreno

1.9k total citations
17 papers, 1.4k citations indexed

About

Montserrat Moreno is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Montserrat Moreno has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Hepatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Montserrat Moreno's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (5 papers) and Alcohol Consumption and Health Effects (5 papers). Montserrat Moreno is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (5 papers) and Alcohol Consumption and Health Effects (5 papers). Montserrat Moreno collaborates with scholars based in Spain, United States and Netherlands. Montserrat Moreno's co-authors include Ramón Bataller, Vicente Arroyo, Pere Ginès, Jordi Colmenero, Marlene Domínguez, Pau Sancho‐Bru, Rosa Miquel, Juan Carlos García‐Pagán, Juan Caballería and Joan Caballería and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Montserrat Moreno

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Montserrat Moreno Spain 15 1.0k 598 530 279 220 17 1.4k
Marlene Domínguez Spain 12 1.1k 1.1× 619 1.0× 711 1.3× 319 1.1× 217 1.0× 14 1.5k
Oriol Morales‐Ibanez Spain 11 768 0.8× 467 0.8× 513 1.0× 183 0.7× 286 1.3× 14 1.3k
Norio Horiguchi Japan 25 960 0.9× 664 1.1× 420 0.8× 327 1.2× 469 2.1× 67 2.0k
Yulia A. Nevzorova Germany 25 738 0.7× 494 0.8× 295 0.6× 146 0.5× 576 2.6× 50 1.6k
Renata Salzano Italy 14 1.1k 1.1× 834 1.4× 185 0.3× 221 0.8× 476 2.2× 21 1.8k
Aileen Dela Peňa Australia 12 639 0.6× 290 0.5× 169 0.3× 216 0.8× 359 1.6× 14 1.3k
Yukito Adachi Japan 13 735 0.7× 353 0.6× 690 1.3× 179 0.6× 394 1.8× 26 1.5k
Cristiana Bertolani Italy 12 1.0k 1.0× 514 0.9× 108 0.2× 251 0.9× 265 1.2× 15 1.5k
Adrien Guillot Germany 20 919 0.9× 569 1.0× 204 0.4× 172 0.6× 491 2.2× 52 1.7k
Benedek Gyöngyösi United States 17 502 0.5× 195 0.3× 354 0.7× 136 0.5× 527 2.4× 23 1.3k

Countries citing papers authored by Montserrat Moreno

Since Specialization
Citations

This map shows the geographic impact of Montserrat Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montserrat Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montserrat Moreno more than expected).

Fields of papers citing papers by Montserrat Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Montserrat Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montserrat Moreno. The network helps show where Montserrat Moreno may publish in the future.

Co-authorship network of co-authors of Montserrat Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Montserrat Moreno. A scholar is included among the top collaborators of Montserrat Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montserrat Moreno. Montserrat Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Morales‐Ibanez, Oriol, Silvia Affò, Daniel Rodrigo‐Torres, et al.. (2015). Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis. Gut. 65(5). 840–851. 14 indexed citations
3.
Moreno, Montserrat, Laura Negrotto, Jordi Río, et al.. (2014). Activation-induced cell death in T lymphocytes from multiple sclerosis patients. Journal of Neuroimmunology. 272(1-2). 51–55. 7 indexed citations
4.
Moreno, Montserrat, Matías Sáenz-Cuesta, Joaquín Castilló, et al.. (2013). Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis. Journal of Neuroimmunology. 263(1-2). 152–154. 11 indexed citations
5.
Affò, Silvia, Marlene Domínguez, Juan José Lozano, et al.. (2012). Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut. 62(3). 452–460. 162 indexed citations
6.
Domínguez, Marlene, Rosa Miquel, Jordi Colmenero, et al.. (2009). Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis. Gastroenterology. 136(5). 1639–1650. 190 indexed citations
7.
Azzalini, Lorenzo, Elisabet Ferrer, Leandra Náira Zambelli Ramalho, et al.. (2009). Cigarette Smoking Exacerbates Nonalcoholic Fatty Liver Disease in Obese Rats. Hepatology. 51(5). 1567–1576. 123 indexed citations
8.
Moreno, Montserrat, Teresa Gonzalo, Robbert J. Kok, et al.. (2009). Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of An Angiotensin Receptor Blocker to Hepatic Stellate Cells in Rats. Hepatology. 51(3). 942–952. 114 indexed citations
9.
Moreno, Montserrat, Felipe Javier Chaves, Pau Sancho‐Bru, et al.. (2009). Ghrelin Attenuates Hepatocellular Injury and Liver Fibrogenesis in Rodents and Influences Fibrosis Progression in Humans. Hepatology. 51(3). 974–985. 133 indexed citations
10.
Sancho‐Bru, Pau, Montserrat Moreno, Manuel Morales‐Ruiz, et al.. (2009). Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells. Liver International. 30(1). 31–41. 39 indexed citations
11.
Colmenero, Jordi, Ramón Bataller, Pau Sancho‐Bru, et al.. (2009). Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. American Journal of Physiology-Gastrointestinal and Liver Physiology. 297(4). G726–G734. 95 indexed citations
12.
Moreno, Montserrat & Ramón Bataller. (2008). Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis. Clinics in Liver Disease. 12(4). 825–852. 69 indexed citations
13.
Domínguez, Marlene, Diego Rincón, Juan G. Abraldeṣ, et al.. (2008). A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis. The American Journal of Gastroenterology. 103(11). 2747–2756. 210 indexed citations
14.
Moreno, Montserrat, Leandra Náira Zambelli Ramalho, Pau Sancho‐Bru, et al.. (2008). Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(2). G147–G156. 75 indexed citations
15.
Sancho‐Bru, Pau, Ramón Bataller, Guillermo Fernández‐Varo, et al.. (2007). Bradykinin Attenuates Hepatocellular Damage and Fibrosis in Rats With Chronic Liver Injury. Gastroenterology. 133(6). 2019–2028. 36 indexed citations
16.
Colmenero, Jordi, Ramón Bataller, Pau Sancho‐Bru, et al.. (2006). Hepatic Expression of Candidate Genes in Patients With Alcoholic Hepatitis: Correlation With Disease Severity. Gastroenterology. 132(2). 687–697. 97 indexed citations
17.
Sancho‐Bru, Pau, Ramón Bataller, Jordi Colmenero, et al.. (2006). Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 291(5). G877–G884. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026